Maudsley Prescribing Guideline im Vergleich zu Waco Guide- Psychopharmacology Nutzung und Statistiken

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. The revised 14th edition of the essential reference for the prescribing of drugs for patients with mental health disorders. Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health. The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems? The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe & effective prescribing of psychotropic agents. Covering both common & complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum & maximum doses, adverse effects, switching medications, prescribing for special patient groups & more. Each clear & concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based. The 14th edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions & all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand & Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry: * Provides succinct coverage of drug treatment of psychiatric conditions & formulating prescribing policy in mental health * Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression & anxiety, borderline personality, eating disorders & many others * Provides advice on prescribing for children & adolescents, older people, pregnant women & other special patient groups * Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses & dopamine super-sensitivity * Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco & caffeine, and treating patients with comorbid physical conditions * Whether in the doctor's office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, 14th Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses & other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy & nursing. Content licensed from printed edition ISBN 10:1119772222 & ISBN 13:9781119772224 SUBSCRIPTION: Please purchase a yearly auto-renewing subscription to receive content access & available updates. Yearly auto-renewing payments- $42.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s): David M. Taylor, Thomas R. E. Barnes, Allan H. Young Publisher: John Wiley & Son Inc. and its affiliates
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

The Waco Guide to Psychopharmacology in Primary Care is a tool developed by faculty of the Waco Family Medicine Residency in consultation with faculty of the Massachusetts General Hospital Psychiatry Academy. Tools combine top-level evidence and expert opinion from world-renowned psychiatrists with primary care expertise from one of the nation’s premier family medicine training programs. This resource is intended for use in communities where the mental and behavioral health needs outpace psychiatric specialty resources. Ideal for primary care clinicians, including physicians, nurse practitioners, and physician assistants. The tools succinctly reflect standard and advanced primary care mental health practices and psychopharmacology for: • Adult • Pediatric & Adolescent • Geriatric • Perinatal and Women’s Mental Health • Substance Use Disorders Special Population considerations offering individually tailored pharmacotherapy recommendations include: • Obesity • Cardiac Impairment • Renal Impairment • Hepatic Impairment • Geriatric Why use The Waco Guide? • High-yield, evidence-based psychopharmacology • In office usability at the point-of-care to enhance medical decision making • Common language and framework for integrated and collaborative care practices • Tools account for cost and medication availability • Titration schedules, monitoring recommendations, and a list of side effects accompany each tool Treatment recommendations for the following disorders: Adult: • Major Depressive Disorder • Anxiety Disorders— Panic Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder • Bipolar Disorder • Posttraumatic Stress Disorder • Acute and Chronic Insomnia • Schizophrenia Spectrum and Other Psychotic Disorders • Acute Stress Disorder • Anorexia Nervosa • Antipsychotic Side Effect Management • Binge Eating Disorder • Bulimia Nervosa • Fibromyalgia • Intermittent Explosive Disorder • Neuropsychiatric Dementia • Obsessive-Compulsive Disorder • Tobacco Use Disorder • ADHD Pediatric & Adolescent Decision Support Tools • ADHD • Depression • Generalized anxiety • Bipolar disorder • Psychosis • Anorexia Nervosa • Binge Eating • Bulimia Nervosa • Autism Spectrum Disorder • Opioid Use Disorder Perinatal (Preconception, Antepartum, and Postpartum)/Women’s Mental Health: • Sexual Interest/Arousal Disorder • Obsessive Compulsive Disorder • Premenstrual Dysphoric Disorder • SSRI-Induced Sexual Dysfunction • Antepartum Tobacco Use Disorder Substance Use Disorders: • Alcohol Use Disorder • Antepartum Alcohol Use Disorder • Tobacco Use Disorder • Benzodiazepine Deprescribing • Opioid Use Disorder • Stimulant Use Disorder The decision support tools included are designed to be informational and to reflect current accepted practices at the time of publication. These tools are not intended to replace professional medical judgment or treatment of specific conditions. Heart of Texas Community Health Center (dba Waco Family Medicine) and the authors accept no responsibility for any damages, obligations, losses, liabilities, costs or expenses arising from use of the decision support tools contained herein. By using this app, you acknowledge that you have reviewed the above and accept these terms.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

Maudsley Prescribing Guidelinevs. Waco Guide- Psychopharmacology Ranking-Vergleich

Vergleichen Sie Maudsley Prescribing Guideline den Ranking-Trend der letzten 28 Tage mit Waco Guide- Psychopharmacology

Rang

Keine Daten verfügbar

Maudsley Prescribing Guideline im Vergleich zu Waco Guide- Psychopharmacology Ranking im Ländervergleich

Vergleichen Sie Maudsley Prescribing Guideline den Ranking-Trend der letzten 28 Tage mit Waco Guide- Psychopharmacology

Alle Kategorien

Keine Daten verfügbar

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
Maudsley Prescribing Guideline VS.
Waco Guide- Psychopharmacology

Dezember 12, 2024